Genomic characterization between HER2‐positive and negative gastric cancer patients in a prospective trial

BACKGROUND: We aimed to clarify the genomic characteristics of HER2‐positive and negative gastric cancer cases that potentially affect tumor progression and treatment response in a prospective trial. METHODS: We collected 80 formalin‐fixed paraffin‐embedded (FFPE) samples (49 HER2+ and 31 HER2‐) fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Qingjiang, Oki, Eiji, Yamada, Teppei, Kashiwada, Tomomi, Sonoda, Hideto, Kataoka, Masato, Kawanaka, Hirofumi, Tsuji, Yasushi, Makiyama, Akitaka, Nakashima, Yuichiro, Ota, Mitsuhiko, Kimura, Yasue, Yoshizumi, Tomoharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469643/
https://www.ncbi.nlm.nih.gov/pubmed/37325934
http://dx.doi.org/10.1002/cam4.6269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469643/
https://www.ncbi.nlm.nih.gov/pubmed/37325934
http://dx.doi.org/10.1002/cam4.6269

Ejemplares similares